Brigham Buhler

Date: 2023-12-27 | Duration: 2h 18m

Category: Health & Medicine, Politics & Media

Episode Overview

Brigham Buhler dives deep into the complexities and challenges facing modern healthcare, particularly focusing on the pharmaceutical industry's influence and the regulatory environment. He discusses how private industry monopolization has led to systemic issues, including contamination scandals and aggressive lobbying that shape FDA decisions. Buhler highlights the tension between innovation and regulation, especially in the realm of compounding pharmacies and peptide therapies, emphasizing that many safe and effective treatments face undue scrutiny due to entrenched interests. The conversation also explores cutting-edge regenerative medicine, including the use of stem cells, extracellular vesicles, and biologics to treat injuries and chronic conditions. Buhler shares insights from his experience working with professional athletes, illustrating how advanced therapies like ultrasound-guided umbilical cord mesenchymal injections and red light therapy accelerate healing and recovery. He stresses the importance of personalized, data-driven care models supported by AI, which could revolutionize patient outcomes by moving healthcare from reactive to proactive management. Throughout, Buhler critiques the profit-driven nature of the healthcare system, advocating for a shift toward patient-centered approaches that leverage technology and scientific advancements.

About Brigham Buhler

Brigham Buhler is the innovative founder of Ways2Well, a cutting-edge functional and regenerative care clinic dedicated to optimizing health through personalized approaches. With a background in health optimization and wellness, Buhler has garnered recognition for his commitment to transforming traditional healthcare into a more holistic experience, focusing on long-term wellness rather than just symptom management. His appearance on the Joe Rogan Experience (episode #2376) highlighted his expertise in regenerative medicine and the impact of lifestyle choices on overall health, making him a compelling voice in the wellness community. Brigham's passion for empowering individuals to take control of their health journey sets him apart in the ever-evolving landscape of modern medicine.

Key Moments

– Pharmaceutical Industry
– FDA Regulations
– Compounding Pharmacies
– Peptide Therapy
– Insurance Companies
– Medical Compliance
– Telemedicine
– AI in Healthcare
– Stem Cell Therapy
– Red Light Therapy
– Chronic Disease Management
– Genetic Testing
– Longevity Science
– Sports Medicine
– Biologics
– Healthcare Economics
– Patient Outcomes
– Ultrasound Guided Injections
0:00:47 – Discussion on public health concerns
0:01:18 – Insidious spread of private industry influence
0:04:38 – Contamination of specimens with HIV
0:06:25 – Pharma lobbying and legal actions
0:07:12 – FDA decision-making process explained
0:10:26 – Gene carrier testing introduction
0:13:52 – Legal risks of indictments and asset seizure
0:16:13 – Debate on peptide therapy safety
0:17:55 – Experience with Abbott Laboratories and FDA compliance
0:19:08 – Chain of custody in drug manufacturing
0:21:08 – Challenges faced by compounding pharmacies
0:23:48 – FDA inspection failures at Eli Lilly
0:25:58 – FDA officials moving to pharmaceutical companies
0:27:37 – Clinician challenges with insurance companies
0:30:40 – Insurance companies skewing facts
0:31:47 – Studies on BPC for spine and joint healing
0:34:53 – Outsourcing pharmaceutical manufacturing
0:36:26 – Discussion on BPC 157 and regulatory concerns
0:37:12 – Nationwide telemedicine prescription fulfillment
0:39:41 – Lack of human safety studies in operating room products
0:42:57 – Resilience of life forms in medical treatments
0:44:31 – Surgical product serial number tracking
0:48:06 – Personal story of loss and solution
0:50:01 – Testosterone and prostate cancer correlation
0:52:45 – Pharmacy benefit managers and drug coverage
0:54:11 – Managed care plan dynamics
0:56:14 – Patient experience at Ways to Well clinic
0:58:17 – Methylfolate detoxification and gut biome testing
1:02:36 – ATP decline and aging effects
1:04:27 – Large language models transforming healthcare
1:08:30 – Extended clinician-patient consultation model
1:14:07 – Limitations of AI based on input data
1:18:51 – Longevity and human lifespan discussions
1:21:15 – Red light therapy reducing inflammation
1:24:05 – Sunlight's impact on testosterone and sex drive
1:32:32 – Profit-driven healthcare system critique
1:41:18 – Regeneration capabilities of salamanders
2:06:05 – Ultrasound guided mesenchymal stem cell injections
2:10:29 – Athlete dedication to recovery treatments

Transcript Excerpt

Starting point is 00:00:00 the Joe Rogan experience Starting point is 00:00:47 There's no public health concern. Starting point is 00:01:18 And, uh, it's a pretty insidious disease and it's spread throughout all of the government. And that disease is private Starting point is 00:01:56 they're going to come to the conclusions Starting point is 00:02:36 back to the Third Reich from this pharmaceutical company saying, thank you so much for your Starting point is 00:03:46 medical industrial complex he warned that if we allow private industry to control monopolize and Starting point is 00:04:38 They inadvertently contaminate thousands of specimens with HIV. Starting point is 00:05:14 Look at this from this article. Starting point is 00:05:44 Anything that I reference will be on there as well. But so jump forward, they infect all these people with HIV. Starting point is 00:06:25 They then lobby with the U.S. government, file and sue the shit out of all of these companies Starting point is 00:07:12 And so time and time again. And so how does the FDA come to these conclusions? It's because a Starting point is 00:07:50 These are short chain amino acids found naturally in nature. Starting point is 00:08:45 former Department of Justice prosecutor to come in and help me build out my compliance program. Starting point is 00:09:39 go pound sand. We're not taking any more in-network contracts. So my options at that point are to lay Starting point is 00:10:26 nine years ago. That was one of the tests we offered was this gene carrier test to identify Starting point is 00:11:11 have been three hundred and fifty dollars. Right. And I'm not blaming the Department of Justice. Starting point is 00:11:59 this is what I explained again on RFK was but but if you didn't do anything wrong, you have nothing to worry about. Starting point is 00:12:45 cutting their reimbursements or not allowing them to participate in their plans. They're scared for Starting point is 00:13:29 of the insurance co...

More Episodes

Frequently asked about this episode

Who was the guest on Joe Rogan Experience #2079?

Brigham Buhler was the guest on JRE #2079. This page includes the episode overview, topics discussed, and related resources.

What topics were discussed on JRE #2079?

On Joe Rogan Experience #2079 with Brigham Buhler, topics include Pharmaceutical Industry, FDA Regulations, Compounding Pharmacies, and Peptide Therapy.

Where can I read the transcript for JRE #2079?

The full searchable transcript for Joe Rogan Experience #2079 with Brigham Buhler is available on this page, along with key topics and timestamps.